Prevention of Cyclical Attacks of Acute Intermittent Porphyria with a Long-Acting Agonist of Luteinizing Hormone–Releasing Hormone

Karl E. Anderson, Irving M. Spitz, Shigeru Sassa, C. Wayne Bardin, Attallah Kappas

Research output: Contribution to journalArticle

65 Scopus citations

Abstract

THE genetic disease acute intermittent porphyria may be exacerbated by a number of factors that are distinct from the inherited deficiency of the heme pathway enzyme, porphobilinogen deaminase (also known as uroporphyrinogen I synthase). These factors include endogenous steroid hormones and their metabolites, drugs, and nutrition.1 2 3 4 5 In some women with acute intermittent porphyria, exacerbations of symptoms occur in relation to the menstrual cycle, and in a minority, disabling premenstrual attacks occur regularly with every cycle.1,2,5 6 7 8 9 We report on a patient in whom premenstrual exacerbations of acute intermittent porphyria, which had previously occurred every month for at least two years, were.

Original languageEnglish (US)
Pages (from-to)643-645
Number of pages3
JournalNew England Journal of Medicine
Volume311
Issue number10
DOIs
StatePublished - Sep 6 1984
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevention of Cyclical Attacks of Acute Intermittent Porphyria with a Long-Acting Agonist of Luteinizing Hormone–Releasing Hormone'. Together they form a unique fingerprint.

  • Cite this